Targeting Nicotinic Receptors to Reduce Inflammation Associated with SLE

StatusActive
Effective start/end date1/03/1828/02/21

Funding

  • Lupus Research Alliance: $200,000.00

Keywords

  • Biotechnology & Drug Development, Cardiovascular Research, Health Disparities (incl Hisp), Immunology, Translational, Womens Health